Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
A phase I study evaluating subcutaneous administration of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced solid malignancies.
Journal: Cancer immunology, immunotherapy : CII
Published: March 02, 2026
Erdafitinib or Erdafitinib Plus Cetrelimab for Patients With Metastatic Urothelial Carcinoma and FGFR Alterations: Final Results From the Phase II NORSE Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 15, 2026
Patient-reported outcomes in non-small cell lung cancer: psychometric evaluation of the PROMIS PF-SF 8c and NSCLC-SAQ in two phase 3 clinical trials.
Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Published: November 11, 2024
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 22, 2023
Myeloablative Carboplatin and Thiotepa With Autologous Stem Cell Rescue for Nonmedulloblastoma High-risk CNS Tumors in Young Children.
Journal: Journal of pediatric hematology/oncology
Published: July 15, 2020
Successful reduced-intensity conditioning hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria with aplastic anemia in two children.
Journal: Pediatric blood & cancer
Published: November 19, 2017
Showing 1-6 of 6
Last Updated: 09/26/2026